Could a quicker, Needle-Free MRI replace the standard scan for Crohn's patients?
NCT ID NCT05354609
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a new, faster MRI technique (diffusion-weighted) to the standard MRI for monitoring Crohn's disease. The new method does not require a contrast injection or bowel cleansing, which patients often dislike. Researchers will check if the new scan is just as good at finding inflammation in the bowel. About 140 adults with Crohn's disease will have both types of MRI on the same day, and doctors will compare the results.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for APPARENT DIFFUSION COEFFICIENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Amiens
Amiens, 80054, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a patient registry unlock the secrets of IBD?
- Can we predict how kids with IBD will respond to treatment?
- Can switching IBD meds heal the gut when symptoms are quiet?
- Can a milk sugar tame IBD symptoms?
- Could an extra flu shot shield vulnerable kids?
- Can a Real-World study reveal the staying power of guselkumab?